跳至主要内容
欧盟官方标签名称词汇表条目 17256

NARINGIN

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 0 个有匹配的监管证据:0 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。

0 个市场有证据
已检查的市场
13
有证据的市场
0
证据缺口
13
已解析的标识符
2

已解析的物质身份

CAS:10236-47-2
EC:233-566-4
成分索引记录:
NARINGIN
化妆品功能: SKIN PROTECTING

4H-1-Benzopyran-4-one, 7-[[2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-, (S)-

1 个匹配或报告的名称
NARINGIN

跨市场监管证据

此处跟踪的 13 个市场均没有以 NARINGIN 为名的已导入规则。

这是关于本清单的陈述,而非关于法律的陈述:没有已导入的规则并不能证明某物质获准使用。规则可能以其他名称存在,或以本词汇表条目未载有的 CAS 或 EC 编号存在,或存在于尚未导入的数据集中。

化学身份与性质

CAS 10236-47-2 的 PubChem 二维化学结构
CAS 10236-47-2PubChem CID 442428

Naringin

Naringin is a disaccharide derivative that is (S)-naringenin substituted by a 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as a metabolite, an antineoplastic agent and an anti-inflammatory agent. It is a member of 4'-hydroxyflavanones, a (2S)-flavan-4-one, a neohesperidoside, a dihydroxyflavanone and a disaccharide derivative. It is functionally related to a (S)-naringenin. — ChEBI

IUPAC 名称
(2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
分子式
C27H32O14
分子量
580.5 g/mol
精确质量
580.17920569 Da
XLogP3
-0.5
拓扑极性表面积
225.0 Ų
氢键供体
8
氢键受体
14
共价单元
1
已定义的立体中心
11

又称

aurantiinNaringosideNaringenin 7-O-neohesperidosideN7TD9J649BNaringenin-7-beta-neohesperidosideCHEBI:288195-Hydroxy-2-(4-hydroxyphenyl)-7-(2-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranosyloxy)-4-chromanonNaringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside]
另有 16 个已报告名称
4',5,7-trihydroxyflavanone 7-rhamnoglucosideNaringenin 7-O-(alpha-L-rhamnosyl-(1->2)-beta-D-glucoside)Citrus naringinineNaringenin GlycosideRefChem:6054naringenin-7-hesperidoside233-566-4Naringin (Standard)Naringenin 7-Rhamnoglucoside4'5-diOH-Flavone-7-rhgluc(s)-yranosyl]oxy]-(2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside(2S)-NaringinSR-01000736681UNII-N7TD9J649BNaringin CRS
外部数据库标识符

来自其他科学数据库的证据

EMBL-EBI ChEBI
标识符精确匹配CHEBI:28819

naringin

A disaccharide derivative that is (S)-naringenin substituted by a 2-O-(α-L-rhamnopyranosyl)-β-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.

配方
C27H32O14
平均质量
580.539 g/mol
单同位素质量
580.17921 Da
形式电荷
0
  • (2S)-flavan-4-one — is a (CHEBI:140377)
  • 4'-hydroxyflavanones — is a (CHEBI:140331)
  • disaccharide derivative — is a (CHEBI:63353)
  • dihydroxyflavanone — is a (CHEBI:38749)
  • neohesperidoside — is a (CHEBI:25495)
  • metabolite — has role (CHEBI:25212)
  • antineoplastic agent — has role (CHEBI:35610)
  • anti-inflammatory agent — has role (CHEBI:67079)
  • (S)-naringenin — has functional parent (CHEBI:17846)
  • metabolite — has role (CHEBI:25212)
  • antineoplastic agent — has role (CHEBI:35610)
  • anti-inflammatory agent — has role (CHEBI:67079)
  • (2S)-flavan-4-one — is a (CHEBI:140377)
  • 4'-hydroxyflavanones — is a (CHEBI:140331)
  • disaccharide derivative — is a (CHEBI:63353)
  • dihydroxyflavanone — is a (CHEBI:38749)
  • neohesperidoside — is a (CHEBI:25495)
其他整理的名称
(2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosideNaringenin 7-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucosideNaringenin 7-O-[alpha-L-rhamnosyl-(1->2)-beta-D-glucoside]Naringenin 7-O-neohesperidosideNaringinNaringoside
来自此来源的交叉引用
  • REGISTRY_NUMBER: 102012 — Reaxys
  • CAS: 10236-47-2 — KEGG COMPOUND
  • CAS: 10236-47-2 — ChemIDplus
  • MANUAL_X_REF: C00000983 — KNApSAcK
  • MANUAL_X_REF: C09789 — KEGG COMPOUND
  • MANUAL_X_REF: HMDB0002927 — HMDB
  • MANUAL_X_REF: LSM-2038 — LINCS
  • MANUAL_X_REF: Naringin — Wikipedia
  • MANUAL_X_REF: NARINGIN — MetaCyc

映射方: Exact CAS cross-reference in the ChEBI compound record. 来源更新: 2018-04-09. 检索时间: 2026-08-31. 打开来源记录

NIH PubChem PUG-View
标识符精确匹配442428

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 76.1% (143 of 188) of all reports. 来源: European Chemicals Agency (ECHA)
  • Signal: Warning 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (23.9%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (23.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (23.9%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 188 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 143 of 188 reports by companies.; There are 6 notifications provided by 45 of 188 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
EMBL-EBI ChEBI精确匹配2026-08-31
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定